WHO and Africa CDC launch $518 million Ebola response plan with no licensed vaccine for Bundibugyo strain

WHO and Africa CDC launched a joint $518 million Ebola response plan on 5 June 2026 for the Bundibugyo virus, a strain with no licensed vaccine or treatment.

A six-month unified response across the DRC, Uganda, and 10 priority countries

The plan runs from June to November 2026 under a "One Response" framework. It integrates the national response plans of the Democratic Republic of the Congo and Uganda with a broader continental structure. Ten additional priority countries are strengthening emergency preparedness, disease surveillance, laboratory testing, and cross-border coordination under the same framework.

"The only way to beat this outbreak is through close partnership, working together under the leadership of the affected countries in one coordinated effort, guided by a simple principle: one plan, one budget, one team. Containing Ebola depends on political commitment, sustained financing, and the trust and engagement of communities." — Dr Tedros Adhanom Ghebreyesus, WHO Director-General

The plan covers emergency coordination, disease surveillance, laboratory testing, infection prevention and control, clinical care, community engagement, research, and logistics. WHO and Africa CDC set a specific condition: countries participating in the response must maintain parallel programs for mpox, cholera, and measles to prevent the Ebola response from drawing resources away from other active outbreaks.

No approved vaccine for Bundibugyo — the clinical gap UAE teams must plan around

The Bundibugyo species is distinct from Zaire ebolavirus, for which the rVSV-ZEBOV vaccine Ervebo is licensed and stockpiled globally. No equivalent product exists for Bundibugyo. Past outbreaks of this strain, most recently in the DRC in 2012, recorded case fatality rates between 25% and 36%. Any imported case reaching a UAE facility would be managed through infection prevention and control protocols alone. No post-exposure vaccine option is available for exposed staff or patient contacts.

"Ebola moves fast. Africa must move faster. This joint plan gives the continent a clear path to act with speed and unity: to save lives, support the affected countries and protect neighbouring communities." — Dr Jean Kaseya, Director-General, Africa CDC

What UAE facility operators need to assess now

Dubai International Airport is one of the world's primary transit corridors between Central and East Africa and Asia. The Ministry of Health and Prevention (MOHAP), the Dubai Health Authority (DHA), and the Department of Health - Abu Dhabi (DOH) each maintain points-of-entry screening protocols under their health security frameworks. The WHO-Africa CDC plan explicitly calls on member states to strengthen screening at points of entry and improve cross-border coordination, a direct signal to Gulf health authorities.

UAE hospital operators, particularly those with emergency departments receiving international travelers, should verify four areas now:

• Viral Hemorrhagic Fever isolation room capacity and negative-pressure availability
• Staff training currency on Bundibugyo clinical presentation, which carries a higher baseline fatality rate than many clinicians have encountered in training scenarios
• Personal protective equipment stockpiles and donning-doffing protocol competency across all shift teams
• Escalation protocols to MOHAP, DHA, or DOH for confirmed or suspected VHF cases, including after-hours notification chains

The $518 million funding target was unmet at plan launch. WHO and Africa CDC have flagged that insufficient early contributions risk disrupting the parallel mpox, cholera, and measles responses across the same region. Healthcare administrators tracking infectious disease risk should watch funding commitments through July 2026 as a leading indicator of whether containment holds to the November timeline.